Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)

NCT00423488 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Diabetes Mellitus, Type 2
Coronary Disease

Interventions

DRUG: Ezetimibe 10 mg
DRUG: Simvastatin 20 mg
DRUG: Ezetimibe Placebo
DRUG: Simvastatin 20 mg
DRUG: Simvastatin Placebo

Sponsor

Organon and Co

Collaborators

[object Object]